ArticleAvicenna journal of phytomedicine
Is opium use a predictor factor for major adverse cardiovascular events in coronary angiography patients?
Article in Avicenna journal of phytomedicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: It is believed that opium, as a narcotic substance, may have protective effects against various disorders such as cardiovascular diseases. The association between opium use and the occurrence of major adverse cardiovascular events (MACE) in patients undergoing angiography was assessed in this study. Materials and Methods: The present descriptive-analytical study was conducted on patients with suspected coronary artery disease (CAD) who underwent angiography at Razi Hospital, Birjand, Iran from June 2018 to November 2020. Participants were considered into two groups: Addicted (i.e. opium users) and non-opium users. Demographic information, medical history, history of opium use, and the SYNTAX score were collected. Results: A total of 2,759 individuals with a mean age of 60.12 ± 18.12 years (ranging from 18 to 94 years) were included. Among the participants, 59.4% were male, with 627 identified as opium users and 2,132 as non-users. The opium user group exhibited significantly lower body mass index (BMI), and frequency of diabetes mellitus and hypertension compared to the non-opium user group (p<0.001). Conversely, the incidence of stenosis ≥50%, moderate SYNTAX score, and MACE incidence were remarkably higher among opium users compared to non-users (p<0.01 to p<0.001). Logistic regression analyses indicated a significant relationship between age, SYNTAX score, prior percutaneous coronary intervention (PCI), and opium use with cardiovascular procedures. Conclusion: These results indicate that opium use is associated with increased stenosis and SYNTAX score, as well as a higher incidence of myocardial infarction and PCI, thereby increasing the odds ratio for cardiovascular events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.